Cutting-Edge Treatments to Prevent Further Organ Damage and Prolong Lives
Amyloidosis is caused by a bone marrow disorder and can be difficult to diagnose because many of the symptoms are similar to more common diseases. Our hematologic malignancy team of experts at University Hospitals Seidman Cancer Center are skilled in the early diagnosis and treatment of amyloidosis. Specialized care is critical to not only symptom management, but also the prevention of organ damage.
Although there is no cure for amyloidosis, specific care plans depend on the type of amyloidosis that is present. The most common type is AL amyloidosis in which the plasma cells in bone marrow produce an abnormal antibody protein. For this reason, stem cell transplant for amyloidosis is a viable treatment option to restrict further amyloid protein production and prolong life.
Stem Cell Transplant a Viable Treatment Option
To provide the most viable treatment option for long-term control over amyloidosis, a stem cell transplant procedure is in many cases the preferred choice. While not every patient is eligible for a stem cell transplant, our skilled transplant team can work with you to determine your eligibility.
Experienced Specialty Trained Amyloidosis Physicians
Our experienced and specially trained team uses the latest diagnostic technology to determine your specific amyloidosis type and then determine the optimal treatment plan. Because amyloidosis can affect so many organs, we bring together a multidisciplinary team that may include: